Exchange: NASDAQ·Updated 07:49 PM EST

VVOS Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 16

Estimated EPS

-$0.30

Reported EPS

-$0.07

Surprise

+76.67%

Estimated Rev

$5.47M

Reported Rev

$6.41M

Surprise

+17.15%

Vivos expects clinical initiatives and payer contract renegotiations to contribute to revenue and margins beginning in the fourth quarter of 2026 and increasingly throughout 2027.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.20
--
--
N/A
Q3 '26
-$0.30
-$0.07
76.67%
BEAT
Q2 '26
-$0.41
-$0.31
24.39%
BEAT
Q1 '26
-$0.45
-$0.52
-14.71%
MISSED
Q4 '25
-$0.50
-$0.58
-17.17%
MISSED

Advertisement|Remove ads.